Akebia (AKBA) Gains 10.51% for June 23

Equities Staff  |

Akebia Therapeutics Inc. (NASDAQ:AKBA) shares gained 10.51% today on 7,597,123 shares - while the stock has a 30 day average of 9,504,045 shares traded.

As of today’s closing price of $0.39 the company has a 50 day moving average of $0.3735.

The company anticipates its next earnings on 2022-08-04.

Akebia has moved 84.26% so far this year.

For technical charts, analysis, and more on Akebia visit the company profile.

About Akebia Therapeutics Inc.

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease. The Company was founded in 2007 and is headquartered in Cambridge, Massachusetts.

To get more information on Akebia Therapeutics Inc. and to follow the company's latest updates, you can visit the company's profile page here: Akebia Therapeutics Inc.'s Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content